Preferred Label : tafluprost;
MeSH note : structure in first source;
CISMeF synonym : AFP-168;
MeSH synonym : 1-methylethyl (5Z)-7-((1R,2R, 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy -1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate;
Is substance : O;
UNII : 1O6WQ6T7G3;
InChIKey : WSNODXPBBALQOF-VEJSHDCNSA-N;
Origin ID : C485333;
UMLS CUI : C1451502;
ATC code(s)
ATC code(s)
CISMeF manual mappings
MeSH term(s) associated for indexing
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
Summary Basis of Decision (SBD) for Saflutan
Tafluprost, 15 mcg/mL, solution, ophthalmic/topical
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00243
2014
false
true
false
Canada
French
English
summary of product characteristics
tafluprost
tafluprost
drug approval
canada
treatment outcome
clinical trials as topic
ophthalmic solutions
administration, ophthalmic
tafluprost
ocular hypertension
glaucoma, open-angle
risk assessment
drug evaluation
prostaglandins F
prostaglandins F
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60007280
2012
France
summary of product characteristics
package leaflet
ophthalmic solutions
tafluprost
eyedrops
tafluprost
---
http://www.has-sante.fr/portail/jcms/c_1121543/saflutan-tafluprost-analogue-de-prostaglandine-en-collyre-synthese-d-avis
2011
France
French
evaluation of the transparency committee
guidelines for drug use
tafluprost
prostaglandins F
ophthalmic solutions
insurance, health, reimbursement
tafluprost
ocular hypertension
glaucoma, open-angle
treatment outcome
tafluprost
prostaglandins F
administration, ophthalmic
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-10/saflutan_-_ct-10571.pdf
http://www.has-sante.fr/portail/jcms/c_1100393/saflutan
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-11/saflutan_ct_10571.pdf
2011
France
French
English
evaluation of the transparency committee
tafluprost
tafluprost
insurance, health, reimbursement
ophthalmic solutions
glaucoma, open-angle
ocular hypertension
prostaglandins F
treatment outcome
tafluprost
instillation, drug
administration, ophthalmic
---